1. Ahima RS. Central actions of adipocyte hormones. Trends Endocrinol Metab 2005; 16: 307-313. - PubMed-
2. Alt N. The effect of feeding time on the quality of metabolic control, day-to-day variability of blood glucose curves and evaluation of IGF-1 levels in cats with diabetes mellitus. Dissertation, University of Zurich, 2006.
3. Alt N, Kley S, Tschuor F, et al. Evaluation of IGF-1 levels in cats with transient and permanent diabetes mellitus. Res Vet Sci 2007; 83(3):331-335. - PubMed -
4. Appleton DJ, Rand JS, Sunvold GD. Plasma leptin concentrations in cats: reference range, effect of weight gain and relationship with adiposity as measured by dual energy X-ray absorptiometry. J Fel Med Surg 2000; 2: 191-199. - PubMed -
5. Appleton DJ, Rand JS, Priest J, et al. Determination of reference values for glucose tolerance, insulin tolerance, and insulin sensitivity tests in clinically normal cats. Am J Vet Res 2001a; 62: 630-636. - PubMed -
6. Appleton DJ, Rand JS, Sunvold GD. Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain. J Fel Med Surg 2001b; 3: 211-228. - PubMed -
7. Bailiff NL, Nelson RW, Feldman EC, et al. Frequency and risk factors for urinary tract infection in cats with diabetes mellitus. J Vet Intern Med 2006; 20: 850-855. - PubMed -
8. Banks WA, Farr SA, Morley JE. The effects of high fat diets on the blood-brain barrier transport of leptin: failure or adaptation? Physiol Behav 2006; 88: 244-248. - PubMed -
9. Baral RM, Rand JS, Catt MJ. Prevalence of feline diabetes mellitus in a feline private practice. J Vet Intern Med 2003; 17: 433.
10. Barroso I. Genetics of type 2 diabetes. Diabet Med 2005; 22: 517-535. - PubMed -
11. Bennett N, Greco DS, Peterson ME, et al. Comparison of low carbohydrate-low fiber diet and a moderate carbohydrate-high fiber diet in the management of feline diabetes mellitus. J Fel Med Surg 2006; 8: 73-84. - PubMed -
12. Biourge V, Nelson RW, Feldman EC, et al. Effect of weight gain and subsequent weight loss on glucose tolerance and insulin response in healthy cats. J Vet Intern Med 1997; 11: 86-91. - PubMed -
13. Biourge VC. Feline diabetes mellitus: nutritional management. Waltham Focus 2005; 15: 36-40.
14. Brennan CL, Hoenig M, Ferguson DC. GLUT4 but not GLUT1 expression decreases early in the development of feline obesity. Domest Anim Endocrinol 2004; 26: 291-301. - PubMed -
15. Butler AE, Janson J, Soeller WC, et al. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 2003; 52: 2304-14. - PubMed -
16. Chan DL, Freeman LM, Rozanski EA, et al. Alterations in carbohydrate metabolism in critically ill cats. J Vet Emerg Crit Care 2006; 16: S7-S13.
17. Cooper GJS. Amylin compared with calcitonin-gene related peptide: structure, biology and relevance to metabolic disease. Endocr Rev 1994; 15: 163-201.
18. Crenshaw KL, Peterson ME, Heeb LA, et al. Serum fructosamine concentration as an index of glycemia in cats with diabetes mellitus and stress hyperglycemia. J Vet Intern Med 1996; 10: 360- 364. - PubMed -
19. Diez M, Nguyen P. The epidemiology of canine and feline obesity. Waltham Focus 2006; 16: 2-8.
20. Dohan FC, Lukens FDW. Experimental diabetes produced by the administration of glucose. Endocrinol 1948; 42: 244-262.
21. Donath MY, Ehses JA, Maedler K, et al. Mechanisms of beta-cell death in type 2 diabetes. Diabetes 2005; 54 suppl. 2: S108-S113. - PubMed -
22. Drucker DJ. Minireview: the glucagon-like peptides. Endocrinol 2001; 142: 521-527. - PubMed -
23. Edelman SV, Weyer C. Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone. Diab Technol Therapeut 2002; 4: 175-189. - PubMed -
24. Elliott DA, Nelson RW, Reusch CE, et al. Comparison of serum fructosamine and blood glycosylated hemoglobin concentrations for assessment of glycemic control in cats with diabetes mellitus. J Am Vet Med Assoc 1999; 214: 1794- 1798. - PubMed -
25. Feldhahn JR, Rand JS, Martin G. Insulin sensitivity in normal and diabetic cats. J Fel Med Surg 1999; 1: 107-115. - PubMed -
26. Feldman EC, Nelson RW, Feldman MS. Intensive 50-week evaluation of glipizide administration in 50 cats with previously untreated diabetes mellitus. J Am Vet Med Assoc 1997; 210: 772-777. - PubMed -
27. Feldman EC, Nelson RW. Feline diabetes mellitus. In: Feldman EC, Nelson RW, eds. Canine and Feline Endocrinology and Reproduction. 3rd ed. St. Louis: Saunders, 2004; 539-579.
28. Fettman MJ, Stanton CA, Banks LL, et al. Effects of neutering on bodyweight, metabolic rate and glucose tolerance of domestic cats. Res Vet Sci 1997; 62: 131-136. - PubMed -
29. Finco DR, Brown SA, Brown CA, et al. Protein and calorie effects on progression of induced chronic renal failure in cats. Am J Vet Res 1998; 59: 575-82. - PubMed -
30. Fineman M, Weyer C, Maggs DG, et al. The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus. Horm Metab Res 2002; 34: 504-508. - PubMed-
31. Franconi F, Loizzo A, Ghirlanda G, et al. Taurine supplementation and diabetes mellitus. Curr Opin Clin Nutr Metab Care 2006; 9 : 32-36. - PubMed -
32. Frank G, Anderson W, Pazak H, et al. Use of high-protein diet in the management of feline diabetes mellitus. Vet Therapeut 2001; 2: 238-245.
33. Furrer D, Tschuor F, Reusch C, et al. Effect of amylin on plasma concentrations of glucose, insulin and glucagon in an arginine stimulation and meal response test in cats. In: Proceedings of the ECVIM Forum 2005.
34. German AJ. The growing problem of obesity in dogs and cats. J Nutr 2006; 136: 1940S-1946S. - PubMed -
35. Goossens MMC, Nelson RW, Feldman EC, et al. Response to insulin treatment and survival in 104 cats with diabetes mellitus (1985-1995). J Vet Intern Med 1998; 12: 1-6. - PubMed -
36. Harper EJ, Stack DM, Watson TDG, et al. Effects of feeding regimens on bodyweight, composition and condition score in cats following ovariohysterectomy. J Small Anim Pract 2001; 42: 433-438. - PubMed -
37. Henson MS, O’Brien TD. Feline models of type 2 diabetes mellitus. ILAR J 2006; 47: 234-242. - PubMed -
38a. Hoenig M. Comparative aspects of diabetes mellitus in dogs and cats. Mol Cell Endocrinol 2002; 197: 221-229. - PubMed -
38b. Hoenig M. The cat as a model for human nutrition and disease. Curr Opin Nutr Metab Care 2006a; 9: 584-588. - PubMed -
39. Hoenig M. Unique aspects of metabolism in obese cats, in Proceedings. 24th ACVIM Forum 2006b; 432.
40. Hoenig M, Alexander S, Holson J, et al. Influence of glucose dosage on interpretation of intravenous glucose tolerance tests in lean and obese cats. J Vet Intern Med 2002; 16: 529-532. - PubMed -
41. Hoenig M, Caffall ZF, McGraw RA, et al. Cloning, expression and purification of feline proinsulin. Domest Anim Endocrinol 2006a; 30: 28-37. - PubMed -
42. Hoenig M, Ferguson DC. Effect of darglitazone on glucose clearance and lipid metabolism in obese cats. Am J Vet Res 2003; 64: 1409-1413. - PubMed -
43. Hoenig M, Ferguson DC. Effects of neutering on hormonal concentrations and energy requirements in male and female cats. Am J Vet Res 2002; 63: 634-639. - PubMed -
44. Hoenig M, Ferguson DC. Impairment of glucose tolerance in hyperthyroid cats. J Endocrinol 1989; 121: 249-251. - PubMed -
45. Hoenig M, Hall G, Ferguson D, et al. A feline model of experimentally induced islet amyloidosis. Am J Pathol 2000; 157: 2143-2150. - PubMed -
46. Hoenig M, McGoldrick JB, deBeer M, et al. Activity and tissue-specific expression of lipases and tumor-necrosis factor alpha in lean and obese cats. Domest Anim Endocrinol 2006b; 30: 333-344. - PubMed-
47. Hoenig M, Thomaseth K, Brandao J, et al. Assessment and mathematical modeling of glucose turnover and insulin sensitivity in lean and obese cats. Domest Anim Endocrinol 2006c; 31: 373-389. - PubMed -
48. Hoenig M, Thomaseth K, Waldron M, et al. Fatty acid turnover, substrate oxidation, and heat production in lean and obese cats during the euglycemic hyperinsulinemic clamp. Domest Anim Endocrinol 2007b; 32: 39-338. - PubMed -
49. Hoenig M, Thomaseth K, Waldron M, et al. Insulin sensitivity, fat distribution and adipocytokine response to different diets in lean, and obese cats before and after weight loss. Am J Physiol Regul Integr Comp Physiol 2007a; 292: R227-R234. - PubMed -
50. Höppener JWM, Nieuwenhuis MG, Vroom TM, et al. Role of islet amyloid in type 2 diabetes mellitus: consequence or cause? Mol Cell Endocrinol 2002; 197: 205-212.
51. Jin Y, Lin D. Fungal urinary tract infections in the dog and cat: a retrospective study (2001-2004). J Am Anim Hosp Assoc 2005; 41: 373-381. - PubMed -
52. Johnson KH, Hayden DW, O'Brien TD, et al. Spontaneous diabetes mellitus - islet amyloid complex in adult cats. Am J Pathol 1986; 125: 416-419.
53. Johnson KH, O’Brien TD, Betsholtz C, et al. Islet amyloid, islet-amyloid polypeptide and diabetes mellitus. New Engl J Med 1989; 321, 513-518.
54. Kanchuk ML, Backus RC, Calvert CC, et al. Neutering induces changes in food intake, body weight, plasma insulin and leptin concentrations in normal and lipoprotein lipase-deficient male cats. J Nutr 2002; 132: 1730S-1732S.
55. Kanchuk ML, Backus RC, Calvert CC, et al. Weight gain in gonadectomized normal and lipoprotein lipase-deficient male domestic cats results from increased food intake and not decreased energy expenditure. J Nutr 2003; 133: 1866-1874.
56. Kaneko JJ, Kawamoto M, Heusner AA, et al. Evaluation of serum fructosamine concentration as an index of blood glucose control in cats with diabetes mellitus. Am J Vet Res 1992; 53: 1797-1801. - PubMed -
57. Kettelhut IC, Foss MC, Migliorini RH. Glucose homeostasis in a carnivorous animal (cat) and in rats fed a high-protein diet. Am J Physiol 1980; 239: R437-R444. - PubMed -
58. Kienzle E. Blood sugar levels and renal sugar excretion after the intake of high carbohydrate diets in cats. J Nutr 1994; 124: 2563S-2567S. - PubMed -
59. Kitamura T, Yasuda J, Hashimoto A. Acute insulin response to intravenous arginine in nonobese healthy cats. J Vet Intern Med 1999; 13: 549-556. - PubMed -
60. Konarkowska B, Aitken J, Kistler J, et al. The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS J 2006; 273: 3614-3624. - PubMed -
61. Laluha P, Gerber B, Laluhova D, et al. Stress hyperglycemia in sick cats: a retrospective study over 4 years. Schweiz Arch Tierheilk 2004; 146: 375- 383. - PubMed -
62. Lazar MA. How obesity causes diabetes: not a tall tale. Science 2005; 307: 373-375. - PubMed -
63. Lederer R, Rand JS, Hughes IP, et al. Chronic or recurring medical problems, dental disease, repeated corticosteroid treatment, and lower physical activity are associated with diabetes in burmese cats. J Vet Intern Med 2003; 17: 433.
64. Leray V, Siliart B, Dumon H, et al. Protein intake does not affect insulin sensitivity in normal weight cats. J Nutr 2006; 136:2028S-2030S.
65. Link KRJ, Rand JS. Reference values for glucose tolerance and glucose tolerance status in cats. J Am Vet Med Assoc 1998; 213: 492-496. - PubMed -
66. Ludvik B, Lell B, Hartter E, et al. Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes. Diabetes 1991; 40: 1615-1619. - PubMed -
67. Lund EM, Armstrong PJ, Kirk CA, et al. Prevalence and risk factors for obesity in adult cats from private US veterinary practices. Intern J Appl Res Vet Med 2005; 3: 88-96.
68. Lutz TA, Ainscow J, Rand JS. Frequency of pancreatic amyloid deposition in cats from south-eastern Queensland. Aus Vet J 1994; 71: 254-256. - PubMed -
69. Lutz TA, Rand JS. Pathogenesis of feline diabetes mellitus. Vet Clin North Am Small Anim Pract 1995; 25: 527-552. - PubMed -
70. Lutz TA, Rand JS, Ryan E. Fructosamine concentrations in hyperglycemic cats. Can Vet J 1995 ; 36 : 155-159.
71. Lutz TA, Rand JS. Plasma amylin and insulin concentrations in normoglycemic and hyperglycemic cats. Can Vet J 1996 ; 37 : 27-34. - PubMed -
72. Lutz TA, Rand JS. Detection of amyloid deposition in various regions of the feline pancreas by different staining techniques. J Comp Pathol 1997; 116: 157-170. - PubMed -
73. Lutz TA. The pancreatic hormone amylin as a centrally acting satiating hormone. Curr Drug Targets 2005; 6: 181-189 - PubMed - .
74. Ma Z, Westermark GT, Johnson KH, et al. Quantitative immunohistochemical analysis of islet amyloid polypeptide (IAPP) in normal, impaired glucose tolerant, and diabetic cats. Amyloid 1998; 5: 255-261. - PubMed -
75. Malecki MT. Genetics of type 2 diabetes mellitus. Diabetes Res Clin Pract 2005; 68 suppl. 1 : S10- S21.
76a. Marshall RD, Rand JS. Comparison of the pharmacokinetics and pharmacodynamics of once versus twice daily administration of insulin glargine in normal cats. J Vet Intern Med 2002; 16: 373.
76b. Marshall RD, Rand JS. Insulin glargine and a high protein-low carbohydrate diet are associated with high remission rates in newly diagnosed diabetic cats. J Vet Intern Med 2004; 18: 401.
77. Martin GJW, Rand JS. Food intake and blood glucose in normal and diabetic cats fed ad libitum. J Fel Med Surg 1999; 1: 241-251. - PubMed -
78. Martin L, Siliart B, Dumon H, et al. Leptin, body fat content and energy expenditure in intact and gonadectomized adult cats: a preliminary study. J Anim Physiol Anim Nutr 2001; 85; 195-199.
79. Martin L, Siliart B. Hormonal consequences of neutering in cats. Waltham Focus 2005; 15: 32- 35.
80. Matveyenko AV, Butler PC. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes. Diabetes 2006; 55: 2106-2114. - PubMed -
81. Matveyenko AV, Butler PC. Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. ILAR J 2006; 47: 225-233. - PubMed -
82. Mazzaferro EM, Greco DS, Turner AS, et al. Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet. J Fel Med Surg 2003; 5: 183-189. - PubMed -
83. McCann TM, Simpson KE, Sham DJ, et al. Feline diabetes mellitus in the UK: the prevalence within an insured cat population and a questionnaire-based putative risk factor analysis. J Fel Med Surg 2007; 9: 289-299. - PubMed -
84. Meurs KM, Fox PR, Miller MW, et al. Plasma concentrations of tumor necrosis factor-alpha in cats with congestive heart failure. Am J Vet Res 2002; 63: 640-642. - PubMed -
85. Mexas AM, Hess RS, Hawkins EC, et al. Pulmonary lesions in cats with diabetes mellitus. J Vet Intern Med 2006; 20: 47-51. - PubMed -
86. Michel KE, Bader A, Shofer FS, et al. Impact of time-limited feeding and dietary carbohydrate content on weight loss in group-housed cats. J. Fel Med Surg 2005; 7: 349-355. - PubMed -
87. Mizisin AP, Nelson RW, Sturges BK, et al. Comparable myelinated nerve pathology in feline and human diabetes mellitus. Acta Neuropathol 2007; 113: 431-442. - PubMed -
88. Muff R, Born W, Lutz TA, et al. Biological importance of the peptides of the calcitonin family as revealed by disruption and transfer of corresponding genes. Peptides 2004; 25: 2027-2038. - PubMed -
89. Nakayama H, Uchida K, Ono K, et al. Pathological observation of six cases of feline diabetes mellitus. Jpn J Vet Sci 1990; 52: 819-825.
90. Nelson RW, Himsel CA, Feldman EC, et al. Glucose tolerance and insulin response in normal-weight and obese cats. Am J Vet Res 1990; 51: 1357-1362. - PubMed -
91. Nelson RW, Feldman EC, Ford SL, et al. Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats. J Am Vet Med Assoc 1993; 203: 821-827. - PubMed -
92. Nelson RW, Griffey SM, Feldman EC, et al. Transient clinical diabetes mellitus in cats: 10 cases (1989-1991). J Vet Intern Med 1999; 13: 28-35. - PubMed -
93. Nelson RW, Scott-Moncrieff JC, Feldman EC, et al. Effect of dietary insoluble fiber on control of glycemia in cats with naturally acquired diabetes mellitus. J Am Vet Med Assoc 2000; 216: 1082- 1088. - PubMed -
94. Nelson RW, Spann D, Elliott DA, et al. Evaluation of the oral antihyperglycemic drug metformin in normal and diabetic cats. J Vet Intern Med 2004; 18: 18-24. - PubMed -
95. Nelson RW. Diabetes mellitus. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. 6th ed. St. Louis: Elsevier Saunders, 2005; 1563-1591.
96. Nguyen P, Leray V, Dumon H, et al. High protein intake affects lean body mass but not energy expenditure in nonobese neutered cats. J Nutr 2004a; 134 suppl.: 2084S-2086S.
97. Nguyen P, Dumon HJ, Siliart BS, et al. Effects of dietary fat and energy on body weight and composition after gonadectomy in cats. Am J Vet Res 2004b; 65: 1708-1713. - PubMed -
98. O’Brien TD, Hayden DW, Johnson KH, et al. High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis. Vet Pathol 1985; 22: 250-261. - PubMed -
99. O'Brien TD, Westermark P, Johnson KH. Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated and dexamethasone treated rats. Diabetes 1991; 40: 1701-1706. - PubMed -
100. O’Brien TD. Pathogenesis of feline diabetes mellitus. Mol Cell Endocrinol 2002; 197: 213-219. - PubMed
101. Panciera DL, Thomas CB, Eicker SW, et al. Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986). J Am Vet Med Assoc 1990; 197: 1504-1508.
102. Petrus DJ, Jackson MW, Kemnitz JW, et al. Assessing insulin sensitivity in the cat: evaluation of the hyperinsulinemic euglycemic clamp and the minimal model analysis. Res Vet Sci 1998; 65: 179-181. - PubMed -
103. Plier ML, Grindem CB, MacWilliams PS, et al. Serum fructosamine concentration in nondiabetic and diabetic cats. Vet Clin Pathol 1998; 27: 34-39. - PubMed -
104. Prahl A, Glickman L, Guptill L, et al. Time trends and risk factors for diabetes mellitus in cats. J Vet Intern Med 2003; 17: 434. - PubMed -
105. Prahl A, Guptill L, Glickman NW, et al. Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals. J Fel Med Surg 2007, doi:10.1016/j.jfms.2007.02.004. - PubMed -
106. Prentki M, Joly E, El-Assad W, et al. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity. Diabetes 2002; 51 suppl. 3: S405-S413. - PubMed -
107. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006; 116: 1802-1812. - PubMed -
108. Rand JS, Bobbermien LM, Hendrikz JK, et al. Over representation of Burmese cats with diabetes mellitus. Aust Vet J. 1997; 75: 402-405. - PubMed -
109. Rand JS, Fleeman LM, Farrow HA, et al. Canine and feline diabetes mellitus: nature or nurture? J Nutr 2004; 134 suppl.: 2072S-2080S. - PubMed -
110. Rand JS, Marshall RD. Diabetes mellitus in cats. Vet Clin North Am Small Anim Pract 2005; 35: 211-224. - PubMed -
111. Rand J. Editorial: Glargine, a new long-acting insulin analog for diabetic cats. J Vet Intern Med 2006; 20: 219-220.
112. Randle PJ. Regulatory interactions between lipids and glucides: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998; 14: 263-283.
113a. Reaven GM. The insulin resistance syndrome: definition and dietary approaches to treatment. An Rev Nutr 2005; 25: 391-406. - PubMed -
113b. Reusch CE, Liehs MR, Hoyer M, et al. Fructosamine. A new parameter for diagnosis et metabolic control in diabetic dogs and cats. J Vet Intern Med 1993; 7: 177-182.
114. Reusch CE, Haberer B. Evaluation of fructosamine in dogs and cats with hypo- or hyperproteinaemia, azotaemia, hyperlipidaemia and hyperbilirubinaemia. Vet Rec 2001; 148: 370-376. - PubMed -
115. Reusch CE, Kley S, Casella M, et al. Measurements of growth hormone and insulin-like growth factor 1 in cats with diabetes mellitus. Vet Rec 2006a; 158: 195-200. - PubMed -
116. Reusch CE, Tschuor F, Kley S, et al. Diabetes mellitus in the cat: a review. Schweiz Arch Tierheilk 2006b; 148: 130-138.
117. Richter M, Guscetti F, Spiess B. Aldose reductase activity and glucose-related opacities in incubated lenses from dogs et cats. Am J Vet Res 2002; 63: 1591-1597. - PubMed -
118. Rogers QR, Morris JG, Freedland RA. Lack of hepatic enzymatic adaptation to low and high levels of dietary protein in the adult cat. Enzyme 1977; 22: 348-356. - PubMed -
119. Root MV, Johnston SD, Olson PN. Effect of prepuberal and postpuberal gonadectomy on heat production measured by indirect calorimetry in male and female domestic cats. Am J Vet Res 1996; 57: 371-374. - PubMed -
120. Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990; 13: 610-630.
121. Scarlett JM, Donoghue S, Saidla J. Overweight cats: prevalence and risk factors. Int J Obes 1994; 18 suppl. 1: S22-S28. - PubMed -
122. Scarlett JM, Donoghue S. Associations between body condition and disease in cats. J Am Vet Med Assoc 1998; 212: 1725-1731. - PubMed -
123. Schermerhorn T. Clinical aspects of feline hepatic glucose metabolism. In: Proceedings of the 23rd ACVIM Forum 2005; 556-558.
124. Schermerhorn T. Pancreatic glucose sensing in dogs and cats. In: Proceedings of the 24th ACVIM Forum 2006; 433-435.
125. Schuit FC, Huypens P, Heimberg H, et al. Glucose sensing in pancreatic beta-cells. Diabetes 2001; 50: 1-11.
126. Slingerland LI, Robben JH, vanHaeften TW, et al. Insulin sensitivity and beta-cell function in healthy cats: assessment with the use of the hyperglycemic glucose clamp. Horm Metab Res 2007; 39: 341- 346. - PubMed -
127. Szabo J, Ibrahim WH, Sunvold GD, et al. Influence of dietary protein and lipid on weight loss in obese ovariohysterectomized cats. Am J Vet Res 2000; 61: 559-565. - PubMed -
128. Takeguchi A, Urabe S, Tanaka A, et al. Activities of enzymes in some types of peripheral leucocytes may reflect the differences in nutrient metabolism between dogs and cats. Res Vet Sci 2005; 78: 21-24. - PubMed -
129. Tanaka A, Inoue A, Takeguchi A, et al. Comparison of expression of glucokinase gene and activities of enzymes related to glucose metabolism in livers between dogs and cats. Vet Res Commun 2005; 29: 477-485. - PubMed -
130. Thoresen SI, Bredal WP. Clinical usefulness of fructosamine measurements in diagnosing and monitoring feline diabetes mellitus. J Small Anim Pract 1996; 37: 64-68. - PubMed -
131. Tschuor F, Furrer D, Kaufmann, et al. Intravenous arginine stimulation test in cats with transient et non-transient diabetes mellitus. In: Proceedings of the 24th ACVIM Forum 2006.
132. Washizu T, Kuramoto E, Abe M, et al. A comparison of the activities of certain enzymes related to energy metabolism in leukocytes in dogs and cats. Vet Res Commun 1998; 22: 187-192. - PubMed -
133. Washizu T, Tanaka A, Sako T, et al. Comparison of the activities of enzymes related to glycolysis and gluconeogenesis in the liver of dogs et cats. Res Vet Sci 1999; 67: 205-206.
134. Weaver KE, Rozanski EA, Mahony OM, et al. Use of glargine and lente insulins in cats with diabetes mellitus. J Vet Intern Med 2006; 20: 234-238. - PubMed -
135. Westermark P, Wernstedt C, O'Brien TD, et al. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 1987; 127: 414-417. - PubMed -
136. Wilkins C, Long RC, Waldron M, et al. Assessment of the influence of fatty acids on indices of insulin sensitivity and myocellular lipid content by use of magnetic resonance spectroscopy in cats. Am J Vet Res 2004; 65: 1090-1099. - PubMed -
137. Williams DL, Heath MF. Prevalence of feline cataract: results of a cross-sectional study of 2000 normal animals, 50 cats with diabetes and one hundred cats following dehydrational crises. Vet Ophthal 2006; 9: 341-349. - PubMed -
138. Yano BL, Hayden DW, Johnson KH. Feline insular amyloid. Ultrastructural evidence for intracellular formation by nonendocrine cells. Lab Invest 1981; 45: 149-56. - PubMed -
139. Zini E, Linscheid P, Franchini M, et al. Expression of genes involved in glucose metabolism in non-diabetic diseased cats. Proceedings European College of Veterinary Internal Medicine 2006.